Captrust Financial Advisors Sarepta Therapeutics, Inc. Transaction History

Captrust Financial Advisors

$33 Billion
Q3 2024

A detailed history of Captrust Financial Advisors transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 3,871 shares of SRPT stock, worth $533,965. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,871

Previous 3,360 15.21%

Holding current value

$533,965

Previous $530,000 8.87%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$124.33 - $156.75 $63,532 - $80,099	511 Added 15.21%	3,871 $483,000
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $106,303 - $153,691	938 Added 38.73%	3,360 $530,000
Q1 2024 May 15, 2024	SELL	$93.7 - $141.53 $229,377 - $346,465	-2,448 Reduced 50.27%	2,422 $313,000
Q4 2023 Feb 14, 2024	SELL	$67.31 - $124.76 $53,376 - $98,934	-793 Reduced 14.0%	4,870 $469,000
Q3 2023 Nov 14, 2023	SELL	$102.5 - $123.59 $24,087 - $29,043	-235 Reduced 3.98%	5,663 $686,000
Q2 2023 Aug 14, 2023	SELL	$106.4 - $157.19 $87,886 - $129,838	-826 Reduced 12.28%	5,898 $675,000
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $92,025 - $122,140	783 Added 13.18%	6,724 $926,000
Q4 2022 Feb 15, 2023	BUY	$100.86 - $132.13 $217,151 - $284,475	2,153 Added 56.84%	5,941 $769,000
Q3 2022 Nov 16, 2022	BUY	$75.71 - $119.24 $24,000 - $37,799	317 Added 9.13%	3,788 $419,000
Q2 2022 Aug 23, 2022	SELL	$62.69 - $88.44 $3,949 - $5,571	-63 Reduced 1.78%	3,471 $260,000
Q2 2022 Aug 16, 2022	BUY	$62.69 - $88.44 $6,707 - $9,463	107 Added 3.12%	3,534 $265,000
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $4,862 - $6,962	77 Added 2.3%	3,427 $268,000
Q4 2021 Feb 14, 2022	SELL	$77.28 - $99.42 $203,014 - $261,176	-2,627 Reduced 43.95%	3,350 $302,000
Q3 2021 Nov 16, 2021	SELL	$65.97 - $92.48 $43,870 - $61,499	-665 Reduced 10.01%	5,977 $553,000
Q2 2021 Aug 16, 2021	SELL	$69.38 - $86.75 $7,007 - $8,761	-101 Reduced 1.5%	6,642 $516,000
Q1 2021 May 17, 2021	SELL	$72.25 - $168.95 $10,259 - $23,990	-142 Reduced 2.06%	6,743 $503,000
Q4 2020 Feb 16, 2021	SELL	$125.56 - $178.74 $8,789 - $12,511	-70 Reduced 1.01%	6,885 $1.17 Million
Q3 2020 Nov 17, 2020	SELL	$127.12 - $172.34 $27,330 - $37,053	-215 Reduced 3.0%	6,955 $984,000
Q2 2020 Aug 14, 2020	SELL	$93.0 - $171.7 $385,485 - $711,696	-4,145 Reduced 36.63%	7,170 $1.19 Million
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $63,020 - $100,704	-765 Reduced 6.33%	11,315 $1.05 Million
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $924,482 - $1.64 Million	12,080 New	12,080 $1.56 Million

Others Institutions Holding SRPT

# of Institutions

530

Shares Held

84.5M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $12.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Sarepta Therapeutics, Inc. Transaction History